---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-060180"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:44:12.858078+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STRATA Skin Sciences expands distribution agreement with Kosmo Meditech through 2026

## Summary
- Agreement with Cutech (Kosmo Meditech parent) extended through December 31, 2026 for direct capital and recurring revenue sales in Korea.
- Defined annual and quarterly performance-based purchase requirements, with STRATA becoming sole provider of gas and consumables.
- CPT codes 96920-96922 revised effective Jan 1, 2024 to 'Excimer laser treatment for psoriasis', impacting Medicare and potentially private insurers.
- STRATA's XTRAC and Pharos are the only excimer laser devices currently marketed in the US that meet the revised code description.

## SEC filing metadata
- accession: 0001140361-23-060180
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036123060180/0001140361-23-060180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036123060180/ef20017695_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-060180
- JSON: https://secwatch.observer/filing/0001140361-23-060180.json
- Plain text: https://secwatch.observer/filing/0001140361-23-060180.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.